Refine Your Results

Click below to filter your search results

"Medications or Drugs"Undo
"Neonatal or Infant"Undo
"Guidelines"Undo

Search Results

Return to List
Results 1–4 of 4
Title Date
1.

Emergent Therapy for Acute-Onset, Severe Hypertension During Pregnancy and the Postpartum Period

Number 623

(Replaces Committee Opinion Number 514, December 2011)

ABSTRACT Acuteonset severe systolic hypertension severe diastolic hypertension or both can occur in pregnant women or women in the postpartum period Introducing standardized evidencebased clinical guidelines for the management of patients with preeclampsia and eclampsia has been demonstrated to re...

February 2015

PDF Format
2.

Magnesium Sulfate Use in Obstetrics

Number 573

ABSTRACT The US Food and Drug Administration advises against the use of magnesium sulfate injections for more than 57 days to stop preterm labor in pregnant women Based on this the drug classification was changed from Category A to Category D and the labeling was changed to include this new warnin...

September 2013

PDF Format
3.

Prevention of Early-Onset Group B Streptococcal Disease in Newborns

Number 485

(Replaces No. 279, December 2002, Reaffirmed 2015)

ABSTRACT In 2010 the Centers for Disease Control and Prevention revised its guidelines for the prevention of perinatal group B streptococcal disease Although universal screening at 3537 weeks of gestation and intrapartum antibiotic prophylaxis continue to be the basis of the prevention strategy th...

April 2011

PDF Format
4.

Magnesium Sulfate Before Anticipated Preterm Birth for Neuroprotection

Number 455

Reaffirmed 2015

Abstract Numerous large clinical studies have evaluated the evidence regarding magnesium sulfate neuroprotection and preterm births The Committee on Obstetric Practice and the Society for MaternalFetal Medicine recognize that none of the individual studies found a benefit with regard to their prim...

March 2010

PDF Format

American Congress of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188 | Mailing Address: PO Box 70620, Washington, DC 20024-9998